- Title
- Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction: Primary Results of the EMBARK-HFpEF Trial
- Creators
- Sanjiv J. Shah - Northwestern UniversityMarzia Rigolli - Bristol-Myers SquibbAtefeh Javidialsaadi - Bristol-Myers SquibbRavi B. Patel - Northwestern UniversitySuhail Khadra - Chicago Medical Research, Hazel Crest, IL, United StatesParag Goyal - Cornell UniversitySean Little - Bristol-Myers SquibbOmar Wever-Pinzon - University of UtahAnjali Tiku Owens - University of PennsylvaniaHicham Skali - Brigham and Women's HospitalPankaj Arora - University of Alabama at BirminghamScott D. Solomon - Brigham and Women's Hospital
- Publication Details
- JAMA cardiology, Vol.10(1), pp.170-175
- Grant note
- Bristol-Myers Squibb (http://data.elsevier.com/vocabulary/SciValFunders/100002491)
- Academic Unit
- UMMG Dept of Medicine - Cardiovascular; Miller School of Medicine
- Language
- English
- Resource Type
- Journal article
- PMID
- 39347697
- Record Identifier
- 991032795855902976
Journal article
Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction: Primary Results of the EMBARK-HFpEF Trial
JAMA cardiology, Vol.10(1), pp.170-175
2025-02-01
PMID: 39347697
Metrics
1 Record Views